MEDVi, a premier telehealth innovator that has already empowered over 100,000 patients, today announced a major expansion of its weight management clinical pathways. As the national conversation shifts toward long-term metabolic health, MEDVi is meeting…

GLP-1 medications like semaglutide and tirzepatide have rapidly become some of the most in-demand treatments for both type 2 diabetes and weight management. With that surge in demand, concerns about availability haven’t disappeared—even as supply…